Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Loebach

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Urology|January 14, 2026
Reply to Editorial Comment on "Unraveling Smooth Muscle-Rich Renal Cell Carcinoma: Clinical, Oncological, Genetic, and Pathological Insights"Braden Millan, Ruben Blachman-Braun, Lauren Loebach, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical RelevanceBraden Millan, Lauren Loebach, Ruben Blachman-Braun, et al.
Urologic Oncology|April 3, 2025
Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative casesRuben Blachman-Braun, Milan Patel, Lauren Loebach, et al.
The Journal of Urology|June 12, 2024
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal MassesMaria B Antony, Zach Kozel, Nikhil Gopal, et al.
Current Urology Reports|May 6, 2026
Is Open Partial Nephrectomy Still an Option in the Robotic Era?Patrick Michael, Ruben Blachman-Braun, Lauren Loebach, et al.
Urologic Oncology|May 28, 2025
Feasibility and perioperative outcomes of re-operative retroperitoneal robotic partial nephrectomyMilan H Patel, Ruben Blachman-Braun, Lauren Loebach, et al.
The Prostate|November 16, 2025
Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility TrialBraden Millan, Nikhil Pramod, Ruben Blachman-Braun, et al.
Urologic Oncology|May 18, 2026
Evaluation of algorithms for predicting new baseline renal function after complex partial nephrectomy for multifocal renal tumorsNityam Rathi, Lauren Loebach, Braden Millan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Estimated blood loss to urine output ratio during partial nephrectomy as a predictor of postoperative acute kidney injury in a hereditary renal cancer-enriched populationLauren Loebach, Ruben Blachman-Braun, Milan H Patel, et al.
Urologic Oncology|September 11, 2025
Metastasectomy outcomes in renal cell carcinoma: insights from hereditary leiomyomatosis and succinate dehydrogenase deficient cohortsMilan H Patel, Ruben Blachman-Braun, Braden Millan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Urology|January 14, 2026
Reply to Editorial Comment on "Unraveling Smooth Muscle-Rich Renal Cell Carcinoma: Clinical, Oncological, Genetic, and Pathological Insights"Braden Millan, Ruben Blachman-Braun, Lauren Loebach, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical RelevanceBraden Millan, Lauren Loebach, Ruben Blachman-Braun, et al.
Urologic Oncology|April 3, 2025
Urinary leak after partial nephrectomy: Insights from a cohort with hereditary, multifocal, and reoperative casesRuben Blachman-Braun, Milan Patel, Lauren Loebach, et al.
The Journal of Urology|June 12, 2024
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal MassesMaria B Antony, Zach Kozel, Nikhil Gopal, et al.
Current Urology Reports|May 6, 2026
Is Open Partial Nephrectomy Still an Option in the Robotic Era?Patrick Michael, Ruben Blachman-Braun, Lauren Loebach, et al.
Urologic Oncology|May 28, 2025
Feasibility and perioperative outcomes of re-operative retroperitoneal robotic partial nephrectomyMilan H Patel, Ruben Blachman-Braun, Lauren Loebach, et al.
The Prostate|November 16, 2025
Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility TrialBraden Millan, Nikhil Pramod, Ruben Blachman-Braun, et al.
Urologic Oncology|May 18, 2026
Evaluation of algorithms for predicting new baseline renal function after complex partial nephrectomy for multifocal renal tumorsNityam Rathi, Lauren Loebach, Braden Millan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Estimated blood loss to urine output ratio during partial nephrectomy as a predictor of postoperative acute kidney injury in a hereditary renal cancer-enriched populationLauren Loebach, Ruben Blachman-Braun, Milan H Patel, et al.
Urologic Oncology|September 11, 2025
Metastasectomy outcomes in renal cell carcinoma: insights from hereditary leiomyomatosis and succinate dehydrogenase deficient cohortsMilan H Patel, Ruben Blachman-Braun, Braden Millan, et al.
Pageof 2